Article

Ezard, Nadine and Clifford, Brendan and Siefried, Krista J and Ali, Robert and Dunlop, Adrian and McKetin, Rebecca and Bruno, Raimondo and Carr, Andrew and Ward, James and Farrell, Michael and Graham, Robert and Haber, Paul and Lubman, Dan and Donoghoe, Mark W and Olsen, Nick and Baker, Amanda and Hall, Michelle and Arunogiri, Shalini and Lintzeris, Nicholas (2025) Lisdexamfetamine in the treatment of methamphetamine dependence: a randomised, placebo-controlled trial. Addiction, 120, (7), pp. 1345-1359. https://pubmed.ncbi.nlm.nih.gov/39701142/.

Fletcher, Kathryn and Ezard, Nadine and Siefried, Krista J and MacDonald, Harriet and Acheson, Liam and Bedi, Gillinder and Guerin, Alexandre and Knock, Elizabeth and Millard, Michael and May, Robert and Brett, Jonathan and Doumany, Jess and Morgan, Celia and Clifford, Brendan (2025) Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial). BMJ Open, 15, (2), e092504. https://doi.org/10.1136/bmjopen-2024-092504.

Freestone, Jack and Siefried, Krista J and Peacock, Amy and Fletcher, Kathryn and Barratt, Monica J and Sutherland, Rachel and Ezard, Nadine and Doumany, Jess and MacDonald, Harriet and Kypri, S and Acheson, Liam and Clifford, Brendan (2025) From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems. International Journal of Drug Policy, 145, 104946. https://doi.org/10.1016/j.drugpo.2025.104946.

Report

Freestone, Jack and Franklin, Erica and Broadbent, Ed and Brown, Jared A and Harvey, Christine and Barratt, Monica J and Lyons, Tom and Camilleri, Andrew and Mason, Clare and Clifford, Brendan (2025) Emerging best practices in the design and dissemination of public drug warnings. Sydney: UNSW.